Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels

L Leanza1, M Zoratti, E Gulbins

  • 1Department of Biology, University of Padova, viale G. Colombo 3, 35121, Padova, Italy.

Insights

Kv1.1, Kv1.3, and Kv1.5 potassium channels interact with Bax, influencing apoptosis. Membrane-permeant drugs targeting these mitochondrial channels can induce cell death, offering potential therapeutic strategies for immune cells and tumors.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • The mitochondrial potassium channel Kv1.3 (mtKv1.3) is a target of Bax, and its inhibition is crucial for apoptosis.
  • Bax mutation at lysine 128 (BaxK128E) prevents apoptosis by abrogating mtKv1.3 inhibition.
  • Previous studies showed membrane-permeant Kv1.3 inhibitors induce apoptosis and reduce tumor volume.

Purpose of the Study:

  • To investigate the role of other Kv channels (Kv1.1, Kv1.5) in apoptosis.
  • To determine if the Bax-Kv1.3 interaction mechanism extends to other Kv channels.
  • To explore the therapeutic potential of targeting mitochondrial Kv channels in macrophages.

Main Methods:

  • Investigated interactions between Bax and Kv1.1, Kv1.5 using transfection and siRNA.
  • Assessed apoptosis sensitivity in Kv-deficient and Kv-overexpressing lymphocytes (CTLL-2).
  • Examined mitochondrial Kv1.3 and Kv1.5 expression in J774 macrophages and their response to specific inhibitors.

Main Results:

  • Kv1.1 and Kv1.5, like Kv1.3, interact with Bax.
  • Restoring Kv1.1 in Kv-deficient lymphocytes re-sensitizes them to apoptosis.
  • Down-regulating Kv1.3 and Kv1.5 in macrophages confers apoptosis resistance.
  • Inhibiting mitochondrial Kv1.3 and Kv1.5 in macrophages induces apoptosis.

Conclusions:

  • The mechanism of Bax-mediated apoptosis involving Kv channels extends beyond Kv1.3 to include Kv1.1 and Kv1.5.
  • Membrane-permeant drugs targeting mitochondrial Kv channels are effective in inducing apoptosis in macrophages.
  • This approach may offer a novel pharmacological strategy for depleting tumor-associated macrophages, potentially inhibiting tumor growth.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...